12 Best Nano Cap Stocks To Buy Now
In this piece, we will take a look at the 12 best nano cap stocks to buy now.
Passage Bio Inc. (PASG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 10,124,576 | $8,040,938 | 0.15% | |
| 2. | Vestal Point Capital Ryan Wilder | 6,052,000 | $4,806,498 | +35% | 0.35% |
| 3. | Lynx1 Capital Management Weston Nichols | 5,057,629 | $4,016,769 | +5% | 1.45% |
| 4. | Tang Capital Management Kevin C. Tang | 1,500,000 | $1,191,300 | 0.12% | |
| 5. | Renaissance Technologies Jim Simons | 1,125,574 | $893,931 | -7% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.84 | 575,195 | Large Shareholder | 8,034,000 | 2023-06-28 | Filing | |
| $0.84 | 617,382 | Large Shareholder | 7,458,805 | 2023-06-27 | Filing | |
| $1.94 | 303,500 | Large Shareholder | 6,841,423 | 2022-05-04 | Filing | |
| $1.93 | 221,500 | Large Shareholder | 6,537,923 | 2022-05-03 | Filing | |
| $5.00 | 50,800 | Large Shareholder | 6,316,423 | 2022-01-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.71 | 39,300 | Large Shareholder | 7,794,569 | 2024-09-19 | Filing | |
| $0.73 | 25,631 | Large Shareholder | 7,833,869 | 2024-09-18 | Filing | |
| $0.73 | 111,400 | Large Shareholder | 7,859,500 | 2024-09-17 | Filing | |
| $0.74 | 63,100 | Large Shareholder | 7,970,900 | 2024-09-16 | Filing | |
| $0.97 | 1,470 | 28,466 | 2024-02-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,959,769 | $5,009,367 | 1.28% | |
| 2. | 2,497,922 | $2,522,901 | 2.03% | |
| 3. | 2,018,882 | $2,039,071 | 0% | |
| 4. | 1,022,563 | $1,032,789 | 0% | |
| 5. | 581,257 | $587,070 | 0.09% |
News See All
Passage Bio, Inc. (NASDAQ:PASG) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the Passage Bio Fourth Quarter and Full Year 2022 Financial Operating Results Conference Call. At this time, all participants are in listen-only mode.
Top 5 Stock Picks of Jacob Doft's Highline Capital Management
In this article, we discuss the top 5 stock picks of Jacob Doft's Highline Capital Management.
Is PASG A Good Stock To Buy Now?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...